Đang tải... (xem toàn văn)
Ngày đăng: 07/07/2018, 09:36
Xem thêm: Drug discovery strategies and methods 2004 makriyannis biegel , III. THE STRUCTURE-BASED DRUG DESIGN CYCLE, D. MODEL BUILDING AND REFINEMENT, L. DEDICATED MOLECULAR BIOLOGY AND PROTEIN PURIFICATION GROUPS ARE ESSENTIAL, II. SRC TYROSINE KINASE AND OSTEOPOROSIS, III. SH2 DOMAINS AND PHOSPHOPEPTIDE BINDING, V. SOLID-PHASE PARALLEL SYNTHESIS AND NONPEPTIDE PHENYL PHOSPHATE LIBRARIES, VI. STRUCTURE-BASED, SMALL-MOLECULE LIBRARIES TO EXPLORE SRC SH2 BINDING, VII. DISCOVERY OF AN IN VIVO EFFECTIVE SRC SH2 INHIBITOR, II. THE MATRIX METALLOPROTEINASE FAMILY, III. ASSIGNMENT OF THE RESONANCES OF THE INHIBITED CATALYTIC DOMAIN OF STROMELYSIN-1, IV. ASSIGNMENT OF THE RESONANCES OF THE INHIBITOR AND NOES BETWEEN THE PROTEIN AND THE INHIBITOR, VI. STRUCTURE OF INHIBITED STROMELYSIN-1, VII. COMPARISON OF INHIBITED STROMELYSIN TO OTHER MMPS, V. MAJOR CLASSES OF CANNABINERGIC LIGANDS, VI. THERAPEUTIC POTENTIAL OF CANNABINERGIC AGENTS, III. ATTEMPTS TO DEVELOP RADIOLIGANDS, A. STRUCTURE–ACTIVITY STUDIES OF TIP(P) PEPTIDES, A. PROTOTYPES AND STRUCTURE–ACTIVITY RELATIONSHIPS, B. CONFORMATIONAL STUDY OF H-TYR-C[-ORN-2-NAL-DPRO-GLY-], II. RESINS AND LINKERS FOR CARBOXYLIC ACID GENERATION, III. RESINS AND LINKERS FOR GENERATION OF AMIDE FUNCTION, V. RESINS AND LINKERS FOR HYDROXYL AND GENERATION OF AMINO FUNCTION, IX. RESINS AND LINKERS FOR GENERATION OF OTHER FUNCTIONS, B. ALLOSTERIC MODULATION ON THE ADENOSINE RECEPTOR, I. DISEASES WITH PROTEIN MISFOLDING, III. INTERMEDIATES IN FIBRIL FORMATION, VI. CLINICAL TRIALS FOR AD TESTING OF POSSIBLE DISEASE-MODIFYING AGENTS, A. THE NATURE OF THE BINDING SITE, C. MODELING OF CONFORMATIONALLY RESTRICTED ANALOGUES, D. THE DEVELOPMENT OF A CLINICAL CANDIDATE, V. REVERSE TRANSCRIPTASE INHIBITORS INTERACTING WITH THE SUBSTRATE BINDING SITE, VI. REVERSE TRANSCRIPTASE INHIBITORS INTERACTING WITH A NONSUBSTRATE BINDING SITE: NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS